Nolan Wood

3.4k total citations
43 papers, 2.6k citations indexed

About

Nolan Wood is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Nolan Wood has authored 43 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 12 papers in Epidemiology and 8 papers in Pharmacology. Recurrent topics in Nolan Wood's work include Antifungal resistance and susceptibility (20 papers), Fungal Infections and Studies (6 papers) and Ocular Infections and Treatments (5 papers). Nolan Wood is often cited by papers focused on Antifungal resistance and susceptibility (20 papers), Fungal Infections and Studies (6 papers) and Ocular Infections and Treatments (5 papers). Nolan Wood collaborates with scholars based in United Kingdom, United States and Belgium. Nolan Wood's co-authors include Lynn Purkins, Diane Kleinermans, D. J. Nichols, Michael J. Allen, Parviz Ghahramani, Bimal Malhotra, Konrad E. Tomaszewski, Richard Sachse, Kuan Gandelman and Keith Tan and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Antimicrobial Agents and Chemotherapy and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Nolan Wood

43 papers receiving 2.5k citations

Peers

Nolan Wood
Ihor Bekersky United States
Robert A. Blum United States
Kazuro Ikawa Japan
I. Nilsson-Ehle Sweden
Domênico Capone Italy
Seo Hyun Yoon South Korea
Norifumi Morikawa Japan
Ronald J. Sawchuk United States
F. Sörgel Germany
Pedro Zapater Spain
Ihor Bekersky United States
Nolan Wood
Citations per year, relative to Nolan Wood Nolan Wood (= 1×) peers Ihor Bekersky

Countries citing papers authored by Nolan Wood

Since Specialization
Citations

This map shows the geographic impact of Nolan Wood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nolan Wood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nolan Wood more than expected).

Fields of papers citing papers by Nolan Wood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nolan Wood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nolan Wood. The network helps show where Nolan Wood may publish in the future.

Co-authorship network of co-authors of Nolan Wood

This figure shows the co-authorship network connecting the top 25 collaborators of Nolan Wood. A scholar is included among the top collaborators of Nolan Wood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nolan Wood. Nolan Wood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wood, Nolan, Sally Kinrade, Mark Sullivan, et al.. (2024). The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation. PLoS neglected tropical diseases. 18(8). e0012351–e0012351. 2 indexed citations
2.
3.
Haughie, Scott, et al.. (2019). Equivalent Systemic Exposure to Fluticasone Propionate/Salmeterol Following Single Inhaled Doses from Advair Diskus and Wixela Inhub: Results of Three Pharmacokinetic Bioequivalence Studies. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 33(1). 34–42. 10 indexed citations
4.
Zrenner, Eberhart, et al.. (2014). Effects of Multiple Doses of Voriconazole on the Vision of Healthy Volunteers: A Double-Blind, Placebo-Controlled Study. Ophthalmic Research. 52(1). 43–52. 23 indexed citations
5.
Luke, David R., Nolan Wood, Konrad E. Tomaszewski, & Bharat Damle. (2011). Pharmacokinetics of sulfobutylether- -cyclodextrin (SBECD) in subjects on hemodialysis. Nephrology Dialysis Transplantation. 27(3). 1207–1212. 40 indexed citations
6.
Malhotra, Bimal, Richard Sachse, & Nolan Wood. (2009). Influence of food on the pharmacokinetic profile of fesoterodine. International Journal of Clinical Pharmacology and Therapeutics. 47(6). 384–390. 11 indexed citations
7.
Malhotra, Bimal, Richard Sachse, & Nolan Wood. (2009). Evaluation of drug–drug interactions with fesoterodine. European Journal of Clinical Pharmacology. 65(6). 551–560. 25 indexed citations
8.
Malhotra, Bimal, Nolan Wood, & Richard Sachse. (2009). Influence of age, gender, and race on pharmacokinetics, pharmacodynamics, and safety of fesoterodine. International Journal of Clinical Pharmacology and Therapeutics. 47(9). 570–578. 29 indexed citations
9.
Malhotra, Bimal, Kuan Gandelman, Richard Sachse, Nolan Wood, & Martin C. Michel. (2009). The Design and Development of Fesoterodine as a Prodrug of 5- Hydroxymethyl Tolterodine (5-HMT), the Active Metabolite of Tolterodine. Current Medicinal Chemistry. 16(33). 4481–4489. 114 indexed citations
10.
Abel, Sylvie, Richard Allan, Kuan Gandelman, et al.. (2008). Pharmacokinetics, Safety and Tolerance of Voriconazole in Renally??Impaired Subjects. Clinical Drug Investigation. 28(7). 409–420. 42 indexed citations
11.
Malhotra, Bimal, Zhiwei Guan, Nolan Wood, & Kuan Gandelman. (2008). Pharmacokinetic profile of fesoterodine. International Journal of Clinical Pharmacology and Therapeutics. 46(11). 556–563. 57 indexed citations
12.
Purkins, Lynn, Nolan Wood, Diane Kleinermans, & D. J. Nichols. (2003). Voriconazole potentiates warfarin‐induced prothrombin time prolongation. British Journal of Clinical Pharmacology. 56(s1). 24–29. 58 indexed citations
13.
Roffey, S. J., Soren Cole, Pierre Comby, et al.. (2003). THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN. Drug Metabolism and Disposition. 31(6). 731–741. 258 indexed citations
14.
Purkins, Lynn, et al.. (2003). Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration. British Journal of Clinical Pharmacology. 56(s1). 37–44. 85 indexed citations
15.
Purkins, Lynn, Nolan Wood, Diane Kleinermans, & D. J. Nichols. (2003). Histamine H2‐receptor antagonists have no clinically significant effect on the steady‐state pharmacokinetics of voriconazole. British Journal of Clinical Pharmacology. 56(s1). 51–55. 31 indexed citations
16.
Wood, Nolan, Keith Tan, Richard Allan, Anitra Fielding, & D. J. Nichols. (2001). Effect of voriconazole on the pharmacokinetics of omeprazole. 41. 2. 2 indexed citations
17.
Wood, Nolan, et al.. (1998). Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis. Birkhäuser Basel eBooks. 49. 49–55. 6 indexed citations
18.
Dingemanse, Jasper, et al.. (1998). Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects. Psychopharmacology. 140(2). 164–172. 18 indexed citations
19.
Zürcher, G., et al.. (1997). Pharmacodynamics of benserazide assessed by its effects on endogenous and exogenous levodopa pharmacokinetics*. British Journal of Clinical Pharmacology. 44(1). 41–48. 22 indexed citations
20.
Lammertsma, Adriaan A., C. J. Bench, Gary Price, et al.. (1991). Measurement of Cerebral Monoamine Oxidase B Activity Using L-[11C]Deprenyl and Dynamic Positron Emission Tomography. Journal of Cerebral Blood Flow & Metabolism. 11(4). 545–556. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ihor Bekersky Breakdown of academic impact, for papers by Robert A. Blum Breakdown of academic impact, for papers by Kazuro Ikawa Breakdown of academic impact, for papers by I. Nilsson-Ehle Breakdown of academic impact, for papers by Domênico Capone Breakdown of academic impact, for papers by Seo Hyun Yoon Breakdown of academic impact, for papers by Norifumi Morikawa Breakdown of academic impact, for papers by Ronald J. Sawchuk Breakdown of academic impact, for papers by F. Sörgel Breakdown of academic impact, for papers by Pedro Zapater
Rankless by CCL
2026